Latest Breaking News On - Company or innocan - Page 6 : comparemela.com

Innocan Pharma Corporation: Innocan Pharma Announces Closing of Private Placement

Innocan Pharma Corporation: Innocan Pharma Announces Closing of Private Placement
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesTel avivIsrael generalIris bincovichEva reuterRamot at tel aviv universityCompany or innocanPrnewswire innocan pharma corporationHebrew university of jerusalemBiskyglobal ltdInnocan pharma corporationPharma corporationClassb warrantCommon shareUnited states securities actCentral nervous system

Innocan Pharma Corporation: Innocan Pharma Announces Private Placement of Units at a 9% Prime Above Share Price

Innocan Pharma Corporation: Innocan Pharma Announces Private Placement of Units at a 9% Prime Above Share Price
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesTel avivIris bincovichEva reuterBi sky global ltdCompany the unitsInnocan pharma corporationCompany or innocanPrnewswire innocan pharma corporationPharma corporationCommon shareClassb warrantUnited states securities actCentral nervous systemGlobal ltdDie experten

Innocan Pharma Announces Private Placement of Units at a 9% Prime Above Share Price

/PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete.

Tel avivUnited statesEva reuterIris bincovichPrnewswire innocan pharma corporationCompany the unitsBi sky global ltdCompany or innocanInnocan pharma corporationPharma corporationCommon shareClassb warrantUnited states securities actCentral nervous systemGlobal ltd

Innocan Pharma Reports Q1 2023 Results including US$1 3M Increase in Revenues Compared to Q1 2022

/PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on.

Tel avivEva reuterIris bincovichInnocan pharma corporationBi sky global ltdPrnewswire innocan pharma corporationCompany or innocanGross profitCash balanceRevenues comparedPharma corporationCentral nervous systemConsumer wellnessJoint venture

Innocan Pharma Corporation: Innocan Pharma Reports Success in a Pre-Clinical Trial of a Liposomal-CBD Injection on a Paralyzed Goat

HERZLIYA, Israel and CALGARY, Alberta, May 8, 2023 /PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a leading pharmaceutical and

Tel avivEva reuterInnocan pharmaIris bincovichPrnewswire innocan pharma corporationBi sky global ltdInnocan pharma corporationCompany or innocanPharma corporationCentral nervous systemConsumer wellnessJoint ventureGefallene big techs